Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
625 JPY | +0.16% | +6.11% | -24.70% |
28/02 | Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis; Down 1.8% | MT |
28/02 | Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company shows low valuation levels, with an enterprise value at 0.55 times its sales.
- The company appears to be poorly valued given its net asset value.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.70% | 269M | - | ||
+9.85% | 54.73B | B- | ||
-16.47% | 15.07B | B | ||
+13.54% | 11.02B | B+ | ||
+5.97% | 8.76B | B | ||
+24.55% | 8.88B | B- | ||
+44.03% | 8.43B | D+ | ||
-9.56% | 8.21B | B- | ||
-14.29% | 6.74B | C- | ||
-12.10% | 6.94B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 6958 Stock
- Ratings CMK Corporation